Powder: -20°C for 3 years | In solvent: -80°C for 2 years
Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 34.00 | |
50 mg | In stock | $ 48.00 | |
100 mg | In stock | $ 93.00 | |
200 mg | In stock | $ 121.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 54.00 |
Description | Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. |
Synonyms | Xylamide, Binoside |
Molecular Weight | 334.42 |
Formula | C18H26N2O4 |
CAS No. | 6620-60-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 55 mg/mL (164.47 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Proglumide 6620-60-6 GPCR/G Protein cholecystokinin SOD TBARS CCK-A CNS antiepileptic secretion Xylamide CAT CCK Receptor CCK-B Binoside inhibit GSH Cholecystokinin Receptor GST antioxidant gastric Inhibitor inhibitor